GRAFT VS HOST DISEASE
Clinical trials for GRAFT VS HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new GRAFT VS HOST DISEASE trials appear
Sign up with your email to follow new studies for GRAFT VS HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New transplant method aims to tame dangerous side effect in blood cancer patients
Disease control TerminatedThis study is testing a method to process stem cell transplants for patients with a serious blood disorder called myelodysplastic syndrome (MDS). The goal is to reduce a common and dangerous complication called graft-versus-host disease (GVHD), where the donor's immune cells atta…
Matched conditions: GRAFT VS HOST DISEASE
Phase: PHASE2 • Sponsor: Guenther Koehne • Aim: Disease control
Last updated Apr 01, 2026 18:26 UTC
-
Lifeline for cancer patients: extended drug access trial
Disease control OngoingThis study provides continued access to the cancer drug ibrutinib for patients who benefited from it in previous clinical trials but cannot obtain it through regular commercial channels. It allows about 300 patients with various blood cancers or solid tumors to keep receiving the…
Matched conditions: GRAFT VS HOST DISEASE
Phase: PHASE4 • Sponsor: Pharmacyclics Switzerland GmbH • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug hope to stop dangerous transplant complication in kids
Disease control OngoingThis study is testing if adding a drug called vorinostat to standard medications can better prevent graft-versus-host disease (GVHD) in children and young adults getting a bone marrow transplant for blood cancers. GVHD is a serious complication where the donor's immune cells atta…
Matched conditions: GRAFT VS HOST DISEASE
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Three-Drug shield aims to protect cancer patients after risky transplants
Disease control OngoingThis study is testing a new combination of three drugs to prevent a dangerous complication called graft-versus-host disease (GVHD) after a half-matched stem cell transplant for blood cancers. The trial involves 27 adults receiving a transplant from a partially matched family dono…
Matched conditions: GRAFT VS HOST DISEASE
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Mar 06, 2026 15:38 UTC
-
Light-Based scanner aims to see inflammation without surgery
Diagnosis TerminatedThis study is testing a new experimental imaging device called MSOT. It uses light and sound waves to take pictures of inflammation through the skin in people with Crohn's disease, colitis, or graft-versus-host disease. The main goal is to check if the device is safe and if its i…
Matched conditions: GRAFT VS HOST DISEASE
Phase: NA • Sponsor: University of Oklahoma • Aim: Diagnosis
Last updated Mar 27, 2026 12:40 UTC
-
Virtual group sessions aim to ease the burden of serious transplant complication
Symptom relief OngoingThis study is testing if a virtual group support program can help adults who developed a serious complication called chronic Graft-Versus-Host Disease (GVHD) after a stem cell transplant. The program aims to improve their quality of life, help them cope with symptoms, and manage …
Matched conditions: GRAFT VS HOST DISEASE
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Mar 23, 2026 15:18 UTC
-
Light therapy trial seeks to soften hardened skin
Symptom relief OngoingThis study is testing whether a specific type of ultraviolet light treatment (UVA-1) can improve symptoms and daily life for people with conditions that cause skin hardening, like scleroderma and morphea. Researchers will give 30 light therapy sessions to 30 participants and meas…
Matched conditions: GRAFT VS HOST DISEASE
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated Mar 12, 2026 13:51 UTC
-
New group program aims to help stem cell transplant survivors cope
Symptom relief OngoingThis study is testing whether a group-based support program called Horizons is practical and helpful for adults living with chronic graft-versus-host disease, a serious complication of stem cell transplants. The program aims to teach coping skills to improve quality of life. Rese…
Matched conditions: GRAFT VS HOST DISEASE
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated Mar 02, 2026 15:22 UTC
-
Researchers create better yardstick for GVHD treatment success
Knowledge-focused OngoingThis study aims to develop better tools to measure whether treatments are working for chronic Graft-versus-Host Disease (GVHD), a serious complication that can occur after stem cell transplants. Researchers are following 383 patients who have started new treatments for chronic GV…
Matched conditions: GRAFT VS HOST DISEASE
Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC
-
Scientists map the immune system to unlock better treatments for gut diseases and transplant complications
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to understand how the immune system works in people with inflammatory bowel disease (IBD), graft-versus-host disease (GVHD), and other related conditions. Researchers will collect blood and tissue samples from about 1,000 participants, including patients and healt…
Matched conditions: GRAFT VS HOST DISEASE
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:18 UTC